Stryker, one of the world’s leading medical technology companies, has opened its high-tech 3D printing facility at Anngrove, Cork – marked by a visit from Taoiseach Micheál Martin TD, the IDA, and other local guests. The new 156,000-square-foot development creates capacity for 600 high-tech jobs in the future, and will help further Stryker’s leadership in med-tech additive manufacturing. Stryker has made significant investments in Anngrove to establish itself as a world leader in this technology, and will continue to invest for growth.
“The new facility and talent will continue to unlock new opportunities that were previously not possible, accelerate innovation globally, and further support our mission to make healthcare better together with our customers. With our experience and proprietary technology, we are excited to impact more patients and drive growth with this additional investment. We are also pleased to expand our talent base in Ireland with engaging roles across a range of disciplines. At Stryker we are committed to a diverse, safe, and inclusive work environment,” said Viju Menon, Group President Global Quality and Operations at Stryker.
Stryker manufactures products to treat bone-related conditions across knees, hips, shoulder, ankle, craniomaxillofacial, and spine, as well as patient-specific solutions for people with significant disease progression often with no alternative. The firm already boasts a 100,000-square-foot facility in Anngrove and employs over 4,000 people at its plants in Cork, Limerick, and Belfast.
Manufacturing on Demand
Stryker’s current 100,000 square foot building, in Anngrove, Cork, includes the AMagine institute
“I am delighted to be at the opening of Stryker’s newly expanded Anngrove facility, a very welcome development for Cork and the South West region. Today’s opening and announcement of the capacity for new jobs is testament to the capability, dedication, and vision of the Stryker team, and of the growth and success of Stryker here. Government will work to ensure Ireland continues to be an attractive location for the med-tech sector, and business in general, supported by our highly-skilled and talented workforce,” said Taoiseach Micheál Martin.
In addition to housing Stryker’s manufacturing facilities, Anngrove is also the worldwide headquarters of the AMagine Institute, which is the center of excellence for additive manufacturing across Stryker. The institute develops breakthrough technologies, ‘from early research and development to full commercial launch and scaling, and deploys these new technologies across its full portfolio of products and services’.
“Stryker has been innovating in additive manufacturing within the MedTech industry for more than 20 years and opened its Anngrove facility in 2016. The expanded facility furthers the company’s four-decade commitment to Ireland and recognises the strong ecosystem of universities, engineering talent and partners such as the IDA. It also builds on Stryker’s outstanding track record for innovation and shows the key role Anngrove plays in the company’s global additive technology research and development. We welcome this exciting development in Anngrove, the potential it brings for future high tech job growth, and look forward to continued success for Stryker in Ireland,” said Martin Shanahan, CEO of IDA Ireland.
You might also like:
MyBone 3D printed bone implant approved for patients in Europe: MyBone is the first commercially available 3D printed bone graft authorized under the Medical Device Regulation 2017/745 (MDR), registered with the Belgium Competent Authority (FAMHP, registration number BE/CA01/1-72228) and ISO 13485 certified.
* This article is reprinted from 3D Printing Media Network. If you are involved in infringement, please contact us to delete it.
Author: Edward Wakefield
Leave A Comment